Latest Views & News

Accrol – ‘successfully navigating inflationary pressures and well positioned’. Really?...

By Steve Moore | Tuesday 17 May 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


“Trading Update - FY22 in line with expectations”-titled announcement from tissue converter group Accrol (ACRL) sounds good given the current macro climate. So what of a current 26p share price?...

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

|